Dailypharm Live Search Close

Yuhan earns KRW253.2B through licensing-out deals in 5 yrs

By Chon, Seung-Hyun | translator Kang, Shin-Kook

24.05.02 05:18:27

°¡³ª´Ù¶ó 0
Yuhan Corp earns KRW 2.5 bil through technology exports in Q1¡¦ with inflow of CDMO licensing-out fees paid from its subsidiaries

Inflow of licensing out fees begins in earnest for the company from 2020... company secures USD 150 million with Leclaza

Yuhan Corp has secured a solid source of revenue with technology licensing fees. Billions of won in profit have been steadily flowing in every quarter through technology licensing deals, the investing company¡¯s development progress, and milestone payments. Yuhan Corp¡¯s cumulative technology fee over the past 5 years amounted to KRW 253.2 billion.

According to the company's report on the 2nd, the company's technology fee revenue in Q1 was KRW 2.5 billion. This is down 64.4% from KRW 7.2 billion in the same period of the past year, but it has been 5 consecutive quarters the company has been collecting revenue since the Q1 in the past year.

 ¡ãYuhan¡¯s quarterly technology fee revenue (Unit: KRW million, Source: Yuhan Corp)


The CDMO technology fee it had received f

Chon, Seung-Hyun(1000@dailypharm.com)
If you want to see the full article, please JOIN US (click)